Skip to content

Study on the Role of Gamma Delta T Cells in Sepsis Immunosuppression and Its Molecular Mechanism

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02361970
Enrollment
84
Registered
2015-02-12
Start date
2014-05-31
Completion date
2015-05-31
Last updated
2017-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

sepsis, gamma delta T cells, immunosuppression

Brief summary

The purpose of the study is to evaluate the status and function of gamma delta T cells in peripheral blood of sepsis patients.

Detailed description

Sepsis therapy is a prominent problem of the modern critical care medicine,and improving the level of sepsis treatment by immune intervention measures is a hot research topic with close attention.Gamma delta T cells is considered as one new T lymphocyte subset in recent years,which playing an important role in resistance to infection,anti-tumor and immune regulating function in the body.First,we played attention to the status and function of gamma delta T cells in peripheral blood of sepsis patients including differentiation marker,subtype and production of related cytokine,and then the molecular mechanism of insufficient gamma delta T cells.At the same time the responsibility of gamma delta T cells of sepsis patients to certain bacteria and viral antigen and the regulation of gamma delta T cells on other natural immune cells including NK cells and mononuclear cells were studied to identify the status and role gamma delta T cells in sepsis immunosuppression by culture in vitro.Further we studied the effect of specific stimulants on proliferation and activation of gamma delta T cells in patients with sepsis and also anti-infection acquired by gamma delta T cells,expecting as an entry point to explore new treatment strategy to sepsis.

Interventions

None listed

Sponsors

West China Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* clinical symptoms of severe sepsis and septic shock * age over 18 years

Exclusion criteria

* preexisting autoimmune disease * patients received immuno-suppressive treatment in the previous 6 months * patients with chronic infection,e.g.tuberculosis,hepatitis or HIV infection,etc. * pregnancy

Design outcomes

Primary

MeasureTime frame
The percentage of activated gamma delta T cellswithin 24h after recruitment

Secondary

MeasureTime frame
The percentage of apoptotic gamma delta T cellswithin 24h after recruitment

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026